T-Rex 2X Long MSTR Daily Target ETF vs Tempus AI — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $40.23 (market cap $930.31M), while Tempus AI trades at $70.35 (market cap $12.77B). The key difference: Tempus AI is far larger — about 13.7× T-Rex 2X Long MSTR Daily Target ETF's market cap, and Tempus AI is trading nearer its 52-week high, T-Rex 2X Long MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Long MSTR Daily Target ETF for 18 Days and Tempus AI for 22 Days on average.
| MSTU | TEM | |
|---|---|---|
Market Cap | $930.31M | $12.77B |
Volume | 4,612,204 | 8,980,490 |
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $451.00 | $99.28 |
52-Week Low | $14.60 | $41.55 |
Typical Hold Time | 18 Days | 22 Days |
Enterprise Value | — | $13.40B |
Signals from Pluang's Aura AI — not financial advice
MSTU shares declined significantly, dropping 13.68% to $39.45 amid bearish technical signals and leveraged ETF volatility. The stock faces pressure from its reverse stock split implementation and weak technical positioning below key resistance levels. Recent trading activity shows heavy volume as investors navigate the leveraged ETF structure that amplifies underlying MicroStrategy stock movements.
The outlook remains challenging with technical indicators signaling bearish momentum and the leveraged ETF structure creating additional volatility risks. Investors face compounded daily value erosion while the fund's performance depends heavily on MicroStrategy's Bitcoin exposure and market sentiment toward cryptocurrency-linked equities.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →